eligibility for glp-1 NEW 2026: Medicare Bridge Program Access to eligible weight-loss medications for approximately $50/month* *Eligibility and physician approval required. Starting July 1, 2026, Medicare will launch a new temporary program called BMI and GLP-1 Weight Loss

The reduction of meta-inflammation may be also related to weight loss: GLP-1 RAs can slow the gastric emptying acting on the autonomic nervous system and reduce hunger through an action on the central nervous system (CNS)

2022;134(sup1):5-17

In another randomised controlled trial, there was an increased incidence of cholelithiasis in patients receiving once daily liraglutide 3mg compared with placebo (0.45% vs 0%) during the 12 months (2)

Adems, durante las primeras semanas o despus de aumentar la dosis pueden aparecer nuseas, pesadez, estreimiento, diarrea o rechazo hacia determinados alimentos

These figures do not represent guaranteed BreezeMeds outcomes, do not apply specifically to compounded formulations, and cannot predict any individual result